Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Compston, J.; Reid, D. M.; Boisdron, J.; Brandi, M.-L.; Burlet, N.; Cahall, D.; Delmas, P. D.; Dere, W.; Devogelaer, J.-P.; Fitzpatrick, L. A.; Flamion, B.; Goel, N.; Korte, S.; Laslop, A.; Mitlak, B.; Ormarsdottir, S.; Ringe, J.; Rizzoli, R.; Tsouderos, Y.; Van Staa, T.; Reginster, J.-Y.

doi:10.1007/s00198-008-0735-7

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Erratum
Published: 04 September 2008

Volume 20, pages 497–498, (2009)
Cite this article

Download PDF

Osteoporosis International Aims and scope Submit manuscript

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Download PDF

J. Compston¹,
D. M. Reid²,
J. Boisdron³,
M.-L. Brandi⁴,
N. Burlet⁵,
D. Cahall⁶,
P. D. Delmas⁷,
W. Dere⁸,
J.-P. Devogelaer⁹,
L. A. Fitzpatrick¹⁰,
B. Flamion¹¹,
N. Goel¹²,
S. Korte¹³,
A. Laslop¹⁴,
B. Mitlak¹⁵,
S. Ormarsdottir¹⁶,
J. Ringe¹⁷,
R. Rizzoli¹⁸,
Y. Tsouderos¹⁹,
T. Van Staa²⁰ &
…
J.-Y. Reginster²¹

850 Accesses
2 Citations
Explore all metrics

The Original Article was published on 05 July 2008

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Erratum to: Osteoporos Int

DOI 10.1007/s00198-008-0670-7

The location of Sanofi-Aventis, the employer of co-author D. Cahall, was incorrectly given as Cincinnati, USA. The true location is Bridgewater, NJ, USA.

Author information

Authors and Affiliations

Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK
J. Compston
University of Aberdeen Medical School, Foresterhill, Aberdeen, AB25 2ZD, UK
D. M. Reid
Hoffman-La Roche Ltd, Basle, Switzerland
J. Boisdron
Metabolic Bone Unit, Laboratory of Molecular Genetics, Department of Internal Medicine, University of Florence, Florence, Italy
M.-L. Brandi
International Osteoporosis Foundation, Nyon, Switzerland
N. Burlet
Sanofi-Aventis, Bridgewater, NJ, USA
D. Cahall
Department of Medicine, University of Lyon and INSERM Research Unit 831, Lyon, France
P. D. Delmas
Amgen, Thousand Oaks, CA, USA
W. Dere
The Arthritis Unit, Université Catholique de Louvain, Brussels, Belgium
J.-P. Devogelaer
Medicines Disease Center, GlaxoSmithKline, King of Prussia, PA, USA
L. A. Fitzpatrick
Laboratory of Physiology and Pharmacology, University of Namur, Namur, Belgium
B. Flamion
Clinical Development, UCB Inc., Smyrna, GA, USA
N. Goel
Novartis Pharma, Berne, AG, Switzerland
S. Korte
AGES PharmMed, Vienna, Austria
A. Laslop
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
B. Mitlak
Icelandic Medicines Control Agency, Seltjarnarnes, Iceland
S. Ormarsdottir
West German Osteoporosis Center (WOZ) and Med. Clinic 4 at Klinikum Leverkusen, Univerity of Cologne, Cologne, Germany
J. Ringe
Division of Bone Diseases, WHO Collaborating Centre for Osteoporosis Prevention, Department of Rehabilitation and Geriatrics, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
R. Rizzoli
Institut de Recherches Internationales Servier, Courbevoie, France
Y. Tsouderos
General Practice Research Database, Medicines and Healthcare Products Regulatory Agency, London, UK
T. Van Staa
Department of Public Health Sciences, University of Liège, Liège, Belgium, Chairman GREES, Liège, Belgium
J.-Y. Reginster

Authors

J. Compston
View author publications
You can also search for this author in PubMed Google Scholar
D. M. Reid
View author publications
You can also search for this author in PubMed Google Scholar
J. Boisdron
View author publications
You can also search for this author in PubMed Google Scholar
M.-L. Brandi
View author publications
You can also search for this author in PubMed Google Scholar
N. Burlet
View author publications
You can also search for this author in PubMed Google Scholar
D. Cahall
View author publications
You can also search for this author in PubMed Google Scholar
P. D. Delmas
View author publications
You can also search for this author in PubMed Google Scholar
W. Dere
View author publications
You can also search for this author in PubMed Google Scholar
J.-P. Devogelaer
View author publications
You can also search for this author in PubMed Google Scholar
L. A. Fitzpatrick
View author publications
You can also search for this author in PubMed Google Scholar
B. Flamion
View author publications
You can also search for this author in PubMed Google Scholar
N. Goel
View author publications
You can also search for this author in PubMed Google Scholar
S. Korte
View author publications
You can also search for this author in PubMed Google Scholar
A. Laslop
View author publications
You can also search for this author in PubMed Google Scholar
B. Mitlak
View author publications
You can also search for this author in PubMed Google Scholar
S. Ormarsdottir
View author publications
You can also search for this author in PubMed Google Scholar
J. Ringe
View author publications
You can also search for this author in PubMed Google Scholar
R. Rizzoli
View author publications
You can also search for this author in PubMed Google Scholar
Y. Tsouderos
View author publications
You can also search for this author in PubMed Google Scholar
T. Van Staa
View author publications
You can also search for this author in PubMed Google Scholar
J.-Y. Reginster
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Compston.

Additional information

The online version of the original article can be found at http://dx.doi.org/10.1007/s00198-008-0670-7.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Compston, J., Reid, D.M., Boisdron, J. et al. Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science. Osteoporos Int 20, 497–498 (2009). https://doi.org/10.1007/s00198-008-0735-7

Download citation

Published: 04 September 2008
Issue Date: March 2009
DOI: https://doi.org/10.1007/s00198-008-0735-7

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Author information

Authors and Affiliations

Corresponding author

Additional information

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation